Next Article in Journal
Risk Factors for Spine Reoperation and Joint Replacement Surgeries after Short-Segment Lumbar Spinal Surgeries for Lumbar Degenerative Disc Disease: A Population-Based Cohort Study
Next Article in Special Issue
Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for Lymphedema Prevention after Axillary Lymph Node Dissection—A Single Institution Experience and Feasibility of Technique
Previous Article in Journal
Cone-Beam Breast Computed Tomography: Time for a New Paradigm in Breast Imaging
Previous Article in Special Issue
Effect of Postoperative Compression Therapy on the Success of Liposuction in Patients with Advanced Lower Limb Lymphedema
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Lymphaticovenous Anastomosis for Age-Related Lymphedema

1
The International Center for Lymphedema, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan
2
Department of Plastic and Reconstructive Surgery, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 739-8551, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2021, 10(21), 5129; https://doi.org/10.3390/jcm10215129
Submission received: 29 September 2021 / Revised: 26 October 2021 / Accepted: 30 October 2021 / Published: 31 October 2021
(This article belongs to the Special Issue Surgical Management of Lymphedema: Past, Present, and Future)

Abstract

:
Introduction: Primary lymphedema is usually caused by intrinsic disruption or genetic damage to the lymphatics but may also be the result of age-related deterioration of the lymphatics. The aims of this study were to determine the characteristics of age-related lymphedema and to assess the effectiveness of lymphaticovenous anastomosis (LVA) in its treatment. Methods: Eighty-six patients with primary lymphedema affecting 150 lower limbs were divided into three groups according to whether the age of onset was younger than 35 years, 35–64 years, or 65 years or older. Indocyanine green (ICG) lymphography was performed, followed by LVA surgery. ICG lymphography images were visually classified according to whether the pattern was linear, low enhancement (LE), distal dermal backflow (dDB), or extended dermal backflow (eDB). The lower extremity lymphedema (LEL) index score was calculated before and after LVA. Lymphatic vessel diameter and detection rates were also recorded. Results: In the ≥65 group, the lymphedema was bilateral in 54 patients and unilateral in 1 patient. There was statistically significant deterioration in the LEL index score with progression from the linear, LE, dDB through to the eDB pattern in the ≥65 group. The lymphatic vessel diameter was significantly greater in the ≥65 group. The rate of improvement was highest in the ≥65 group. Conclusion: Age-related lymphedema was bilateral and deterioration started distally. The lymphatic vessels in patients with age-related lymphedema tended to be ectatic, which is advantageous for LVA and may increase the improvement rate.

1. Introduction

Primary lymphedema with onset after 35 years of age is known as lymphedema tarda and is generally caused by intrinsic disruption or genetic damage in the lymphatic drainage system. Some evidence suggests that lymphedema could also be caused by an age-related decline in lymphatic pump function [1,2,3,4,5]. However, the characteristics of age-related lymphedema are not well understood and no treatment guidelines for this condition have been established.
The aims of this study were threefold: to determine whether aging could be a cause of lymphedema in patients with onset after age 65 years, which is defined as “elderly” by the World Health Organization [6]; to clarify its characteristics of these patients; and to assess the effectiveness of the now widely used surgical method of lymphaticovenous anastomosis (LVA) [7,8,9] in these patients.

2. Patients and Methods

This retrospective study included patients with lower limb lymphedema treated by LVA at Hiroshima University Hospital from May 2017 to December 2018. The study was approved by our institutional review board (approval number: E-1413) and conducted reference to the Declaration of Helsinki and the STROBE guidelines (http://www.strobe-statement.org, accessed on 7 April 2017). All patients submitted written informed consent.
The exclusion criteria were need for support/auxiliary aids for ambulation; body mass index (BMI) ≥ 35; edema controllable by conventional compression therapy using elastic stockings; history of a major invasive procedure to treat pelvic cancer including uterine cancer, prostate cancer, rectal cancer, metastatic cancer, and inguinal lymphadenectomy, radiation therapy to the lower limbs or abdomen, chronic cardiac failure, chronic kidney failure, hepatic cirrhosis, hypoproteinemia, deep venous thrombosis, phlebostasis or venous reflux, thyroid disorder, edema caused by other endocrine disorder, drug-related edema, or arteriovenous malformation. Preoperatively, the compression stocking pressure was adjusted to between 18 and 32 mmHg at the highest tolerable pressure.
ICG lymphography were performed in all patients. First, to assess lymphatic function by measuring transit time, which is the time required for the dye to reach the lymph nodes in the groin [10]. During this procedure, the patient lay in the supine position and repeated plantar flexion and dorsiflexion movements of the ankles and toes to reduce the delay in flow that often occurs during passage across the ankle joints and affects the ICG lymphography images acquired [11]. Lymphoscintigraphy was also performed when transit time was ≥10 min despite lying supine and performing these regular movements [12]. A diagnosis of lymphedema was made based on an abnormal lymphoscintigram with delayed transit of radiolabeled colloid (i.e., longer than 50 min) [13,14,15,16,17] considering the existence of lower limb edema although there are no causes of edema except for delayed lymphatic transport.
The patients were divided into three groups according to their age of onset, younger than 35 years, 35–64 years, or 65 years or older. ICG lymphography images were recorded in the plateau phase (i.e., 12–18 h after the injection or on the following day). The ICG image patterns were then classified according to their laterality, whether to bilateral or unilateral, and were then classified according to whether the pattern seen as linear (the fluorescent lymphatic vessels were seen as a linear pattern between the injection site and the inguinal nodes), low enhancement (LE; a linear pattern is observed only around the ankle joint without enhancement in the proximal portion), distal dermal backflow (dDB; deterioration in the enhanced lymphatics only in the distal portion of the lower extremity below the knee), or extended dermal backflow (eDB; deterioration extended over the knee to the groin) as shown in Supplementary Figure S1. Obtained ICG images were reviewed by two plastic surgeons working independently [18].
LVAs were performed under local anesthesia in all cases along linear pattern or along the greater saphenous vein course in the area of DB pattern or no enhancement. The LVA procedures were an end-to-end manner using 11-0 or 12-0 nylon micro sutures under a surgical microscopes. LVAs are performed by two surgeons simultaneously in the same way previously reported [18] within the limited time of 3 h. The number of LVAs was determined by this time limit. The success of the LVAs was reviewed by two plastic surgeons working independently to reduce the observer’s bias.
The laterality of the lymphedema, the time interval between age of onset and LVA surgery, and the number of LVAs were recorded. A microscale (Kono Seisakusyo Co., Ltd., Ichikawa, Japan) was used to measure the diameter of each lymphatic vessels. Measurements were performed by the two plastic surgeons working independently. The mean vessel diameter for each extremity was calculated. The lymphatic detection rate in each extremity was calculated by dividing the total number of skin incision cites for each extremity by the number of cite where at least one lymphatic suitable for anastomosis was detected. Compression therapy was resumed in the same way as before surgery 1 week after LVA.
The lower extremity lymphedema (LEL) index was calculated [19]. Circumferences were measured at the foot, ankle, knee, 10 cm below the knee, and 10 cm above the knee for each extremity with the patient in the supine position. Sum of the squares of the circumference in five areas was divided by the BMI. A lower score of LEL index indicates less severe edema. All measurements were performed in the outpatient clinic in the morning by a nurse not involved in the research and randomly assigned to each patient on the day of measurement.
The postoperative reduction in volume was calculated as follows:
[{(preoperative LEL) − (postoperative LEL)}/(preoperative LEL)] × 100 (%) = the improvement rate.

Statistical Analysis

Data are shown as the mean and standard deviation (range). The LEL index and lymphatic vessel diameters recorded in the ≥65 group were compared according to type of lymphography pattern using the Tukey–Kramer test. The laterality of the lymphedema and the distribution of the ICG pattern were compared between the <35 group, 35–64 group, and ≥65 group using the chi-squared test.
The LEL index, lymphatic detection rate, lymphatic vessel diameter, number of LVAs performed, number of skin incisions for LVA, rate of improvement in the LEL index, and interval between age of onset and LVA surgery were compared between the three age groups using the Tukey–Kramer test. BMI was compared according to the type of lymphography pattern independent of age using the Tukey–Kramer test. All statistical analyses were performed using Statcel 4 software (OMS Publishing, Inc., Tokyo, Japan). A p-value of less than 0.05 was considered statistically significant.

3. Results

This study included an initial 490 patients with lower extremity lymphedema who underwent lymphedema surgery at our institution between May 2017 and December 2018. Among them, 4 patients in the <35 group, 189 patients in the 35–64 group, and 211 patients in the ≥65 group were excluded by the exclusion criteria (Supplementary Materials, Table S1). Eighty-six patients with 150 edematous lower limbs who showed delayed transit time on both ICG lymphography and lymphoscintigraphy were enrolled in the study. There were no complications such as lymphorrhea or delayed wound healing during LVA procedures and postoperative course. None of the patients developed cellulitis during the study period. None of the patients had a negative ICG study. All patients had a diagnosis of lymphedema or edema caused by lymphatic stasis or delay. According to the International Society of Lymphology scoring system for lymphedema [20], 42.7% had stage I, 44% had stage II, and 13.3% had stage III (Table 1). Most of the patients in the <35 group were older than 10 years of age with the exception of 2 cases (Supplementary Materials, Figure S2).
There was significant deterioration in the LEL index (Figure 1) and a significant decrease in lymphatic vessel diameter (Figure 2) with progression from the linear, LE, dDB through to the eDB pattern in the ≥65 group. A bilateral pattern was found significantly more frequently in older patients than in younger patients (Figure 3). We detected the eDB pattern in most patients in the <35 group; however, other types of ICG pattern were seen in the older patients (Figure 4). There was statistically significant deterioration in the LEL index with decreasing age of onset (Figure 5).
The lymphatic detection rate (Figure 6), lymphatic vessel diameter (Figure 7), and number of LVAs performed increased significantly with increasing age of onset (Supplementary Materials, Figure S3), although there was no significant difference in the number of skin incisions for LVA among the groups (Supplementary Materials, Figure S4). The rate of improvement in the LEL index after LVA was significantly greater in older patients (Figure 8). The interval between the age of onset and LVA surgery decreased significantly with increasing age (Figure 9). Independent of age, BMI was highest in the LE pattern (Supplementary Materials, Figure S5).

4. Discussion

Leg edema is a common problem in older patients and has a wide range of possible causes. The differential diagnosis includes systemic illness such as chronic cardiac failure, hepatic cirrhosis, hypoproteinemia, or a thyroid disorder, a pelvic invasion, or venous insufficiency, and various drug-related edema [21]. In this study, we carefully excluded these causes and diagnosed lymphedema based on delayed lymphatic transport seen on ICG lymphography. In general, lymphedema with no obvious cause is classified into primary lymphedema, even when the onset is in adulthood. However, there are various features and cause in primary lymphedema. In our study, the features of primary lymphedema varied according to age of onset. First, the patients younger than 35 years in our study had a tendency to be unilateral while bilateral in older patients. Second, the lymphatic diameter was greater in older patients in the early stage than in younger patients or older patients in the advanced stage. Therefore, it was reasonable to believe that primary lymphedema in our study has varied causes depend on its onset age. Besides, it is also inferred that lymphatic pump function was deteriorated by age-related causes and the bilateral primary lymphedema appeared in the older patients in this study.
Decreases in contraction frequency [3], pumping activity, systolic lymph flow velocity [4], and lymphatic vessel density [22] have been demonstrated in animal models of aging lymphatic collecting ducts. Aging is speculated to be dominant a chronic inflammatory process [23,24,25]. This progressed chronic inflammatory process would cause deleterious vascular changes including lymphatic pump function in aging [3]. Furthermore, lymph drainage has been shown to decrease with advancing age in clinical studies using lymphoscintigraphy [1] and ICG lymphography [5]. One animal study found that older animals have significantly greater lymphatic vessel diameters than younger adults at the same anatomical location [26]. It can be speculated that the same pathophysiological changes occur in humans. In Japanese population, mean diameter of lymphatics in the lower extremities is around 0.5 mm in our empirical data [27]. Therefore, we speculate that a functional disorder of the lymphatics may be a common cause of edematous lower extremities in older patients.
In this study, the characteristics of age-related lymphedema were bilateral involvement and deterioration in the LEL index with progression from the linear, LE, dDB through to the eDB pattern on ICG lymphography. These features indicate that lymphedema progressed from the distal region and not from the proximal area, which is different from the course of deterioration that occurs with secondary lymphedema caused by an obstruction such as pelvic cancer [28]. In secondary lymphedema, lymphatic function is initially retained; however, lymph then starts to accumulate in the proximal region [29] and extends distally. In contrast, age-related lymphatic deterioration is suspected to develop across the entire area. The contractile force in the lymphatics also decreases, leading to a reduction in the amount of lymph that can be transported in the lymphatics. Lymph then starts to accumulate in the distal region owing to the gravity effect, unlike in secondary lymphedema associated with an obstruction.
As reported previously [30,31], our younger cases of lymphedema tended to be unilateral rather than bilateral. Schook et al. found that lymphedema was more likely to be bilateral in patients presenting in infancy or childhood than in those presenting in adolescence and that unilateral involvement was more likely in patients whose onset was during adolescence [31]. Their findings correspond well with the results of our study.
Furthermore, the younger patients were significantly worse than older patients in LEL index with a DB pattern in both the lower leg and thigh areas. It is difficult to determine whether these features reflect a congenital or acquired physiological defect in younger patients with unilateral lymphedema. However, it is assumed that these patients have congenitally vulnerable lymphatic vessels and that minor events, for example, an inflammatory reaction or mild trauma cause lymphedema that is too subtle to be classified as secondary lymphedema. This type of impaired lymphatic function is more likely to be secondary to errors in fetal development, although the lymphedema in the younger patients in our study may have been an acquired insufficiency. Alternatively, an insufficiency may exist from birth and compensated for by the lymphatic system until there is subtle invasion resulting in overload of lymphatic transport capacity [32,33,34]. Therefore, our younger patients with unilateral lymphedema were likely to have a combination of secondary and congenital characteristics that resulted in more severe lymphedema.
LVA is assumed to be easier to perform in older patients because their lymphatic vessels tend to be ectatic, which results in a high detection rate and enables more LVAs to be performed. In a previous study, patients with secondary lymphedema were found to have more ectatic lymphatic vessels because endolymphatic pressure increased with worsening lymphedema [35]. As the secondary lymphedema progressed, smooth muscle cells in the lymphatics were transformed into collagen fibers, leading to irreversible contraction of these vessels. In the terminal stage of lymphedema, lymphatics lose their transport capacity and become either narrowed or completely obstructed [35]. However, in age-related lymphedema, the decreases in contraction frequency and activity cause pathophysiologic changes, so that the lymphatic vessels are dilated from an early stage. As the lymphedema progresses, smooth muscle cells in the lymphatics are transformed into collagen fibers, which leads to irreversible contraction of the lymphatics in the same way as in secondary lymphedema. In our study, the lymphatics in these patients were initially dilated when the linear or LE pattern was present; however, as the lymphedema progressed (with worsening of the LEL index value), the lymphatic diameter decreased in the order of dDB to eDB until the end stage of lymphedema, as in the unilateral pattern seen in younger patients. LVA is best performed in the early stages, even in patients with age-related lymphedema [36,37,38]. We believe that age-related lymphedema should be treated because of its progressive nature and have focused more recently on prevention and risk reduction [39].
In the present study, patients <35 years of age had the most severe disease features and the least favorable surgical outcomes. Furthermore, our younger patients had longer interval between disease onset and LVA. This pronounced tendency has yet to be explained but may lead to smaller diameter of lymphatics and worse outcomes owing to long lasting chronic damage to lymphatics.
The LE pattern is often seen on ICG lymphography in patients with a high BMI [40]. In this study, patients with this pattern also had the highest BMI; however, a significant difference in the ICG pattern was seen only between LE and eDB and between dDB and eDB, which may be explained by the fact that patients with a BMI ≥35 were excluded from the study. According to previous reports, the diameter of lymphatic was significantly greater in the obese group than in the nonobese group [40]. The results are consistent with studies in hypercholesterolemic mice [41,42]. The mechanism how obesity impairs the lymphatic function was unknown. However, a hypothesis is that the amount of lymph produced by obesity patients increases as BMI increases and the amount of lymphatic flow required to transport increases while there is no increase in the muscle pumping function. However, the capability of lymphatic vessels is limited, which leads to cause the relatively overloaded lymphatic fluid.
We receive the impression that the obesity induced lymphedema starts from distal part like age-related lymphedema through our experience at present, however, further investigation is necessary.
Recurrent cellulitis in the lower extremities is common in the elderly [43,44]. Decreased contractile activity in the lymphatics was suspected in the elderly patients with edema in our study. Many factors contribute to edema and cellulitis in this age group; however, it is assumed that lymphatic deterioration contributes to these symptoms, because the condition of the lymphatics is closely related to immune status and a lymphedematous limb is immunocompromised [45]. LVA is a promising surgical treatment to prevent cellulitis in patients with a lymphatic disorder [46,47]. Compression therapy is likely to be burdensome for elderly people [48] and LVA would decrease this burden and the risk of infection in this age group.

5. Conclusions

The characteristics of age-related lymphedema are bilateral involvement and deterioration that starts distally rather than proximally. Furthermore, the lymphatics in patients with age-related lymphedema are ectatic, which means that the detection rate is high. LVA is easier to perform. LVA may be more effective in older patients with age-related lymphedema than in their younger counterparts with primary lymphedema.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/jcm10215129/s1, Table S1: The number of cases excluded from the study Figure S1: Patterns of age-related primary lymphedema in the lower extremities seen on indocyanine green lymphography, Figure S2: Number of cases divided by its onset age in <35 group, Figure S3: Number of performed LVAs according to age of onset, Figure S4: Number of skin incisions for LVA, Figure S5: ICG pattern according to BMI independent of age. Patients with the LE pattern had the highest BMI.

Author Contributions

Conceptualization, S.Y. and I.K.; methodology, S.Y. and H.I.; software, S.Y.; validation, T.U., A.S. and S.N.; formal analysis, S.Y. and H.I.; investigation, S.Y. and H.I.; resources, S.Y.; data curation, S.R. and T.M.; writing—original draft preparation, S.Y.; writing—review and editing, S.Y.; visualization, S.Y and H.I.; supervision, S.Y.; project administration, S.Y.; funding acquisition, S.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study protocol was approved by our institutional review board (approval number: E-1413). The study was conducted in accordance with the declaration of Helsinki and the STROBE guidelines (http://www.strobe-statement.org, accessed on 7 April 2017).

Informed Consent Statement

All study participants provided written informed consent.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bull, R.H.; Gane, J.N.; Evans, J.E.; Joseph, A.E.; Mortimer, P.S. Abnormal lymph drainage in patients with chronic venous leg ulcers. J. Am. Acad. Dermatol. 1993, 28, 585–590. [Google Scholar] [CrossRef]
  2. Rockson, S.G. The lymphatic biology of aging. Lymphat Res. Biol. 2012, 10, 45. [Google Scholar] [CrossRef]
  3. Gashev, A.A.; Chatterjee, V. Aged Lymphatic Contractility: Recent Answers and New Questions. Lymphat Res. Biol. 2013, 11, 2–13. [Google Scholar] [CrossRef] [Green Version]
  4. Zolla, V.; Nizamutdinova, I.T.; Scharf, B.; Clement, C.; Maejima, D.; Akl, T.; Nagai, T.; Luciani, P.; Leroux, J.; Halin, C.; et al. Aging-related anatomical and biochemical changes in lymphatic collectors impair lymph transport, fluid homeostasis, and pathogen clearance. Aging Cell 2015, 14, 582–594. [Google Scholar] [CrossRef] [PubMed]
  5. Unno, N.; Tanaka, H.; Suzuki, M.; Yamamoto, N.; Mano, Y.; Sano, M.; Saito, T.; Konno, H. Influence of age and gender on human lymphatic pumping pressure in the leg. Lymphology 2011, 44, 113–120. [Google Scholar] [PubMed]
  6. World Health Organization (WHO). Men, Ageing and Health; WHO: Geneva, Switzerland, 2001. [Google Scholar]
  7. Koshima, I.; Nanba, Y.; Tsutsui, T.; Takahashi, Y.; Itoh, S. Long-Term Follow-Up After Lymphaticovenular Anastomosis for Lymphedema in the Leg. J. Reconstr. Microsurg. 2003, 19, 209–215. [Google Scholar] [PubMed]
  8. Chang, E.I.; Skoracki, R.J.; Chang, D.W. Lymphovenous Anastomosis Bypass Surgery. Semin. Plast. Surg. 2018, 32, 22–27. [Google Scholar] [PubMed]
  9. Akita, S.; Mitsukawa, N.; Kuriyama, M.; Hasegawa, M.; Kubota, Y.; Tokumoto, H.; Ishigaki, T.; Hanaoka, H.; Satoh, K. Suitable therapy options for sub-clinical and early-stage lymphoedema patients. J. Plast. Reconstr. Aesthetic Surg. 2014, 67, 520–525. [Google Scholar] [CrossRef]
  10. Unno, N.; Nishiyama, M.; Suzuki, M.; Yamamoto, N.; Inuzuka, K.; Sagara, D.; Tanaka, H.; Konno, H. Quantitative Lymph Imaging for Assessment of Lymph Function using Indocyanine Green Fluorescence Lymphography. Eur. J. Vasc. Endovasc. Surg. 2008, 36, 230–236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Yoshida, S.; Koshima, I.; Imai, H.; Sasaki, A.; Fujioka, Y.; Nagamatsu, S.; Yokota, K.; Harima, M.; Yamashita, S.; Tashiro, K. Indocyanine green lymphography findings in older patients with lower limb lymphedema. J. Vasc. Surg. Venous Lymphat. Disord. 2020, 8, 251–258. [Google Scholar] [CrossRef] [PubMed]
  12. Yamamoto, T.; Narushima, M.; Yoshimatsu, H.; Yamamoto, N.; Oka, A.; Seki, Y.; Todokoro, T.; Iida, T.; Koshima, I. Indocyanine green velocity: Lymph transportation capacity deterioration with progression of lymphedema. Ann. Plast. Surg. 2013, 71, 591–594. [Google Scholar] [CrossRef] [PubMed]
  13. Gloviczki, P.; Calcagno, D.; Schirger, A.; Pairolero, P.C.; Cherry, K.J.; Hallett, J.W.; Wahner, H.W. Noninvasive evaluation of the swollen extremity: Experiences with 190 lymphoscintigraphic examinations. J. Vasc Surg. 1989, 9, 683–689. [Google Scholar] [CrossRef] [Green Version]
  14. Szuba, A.; Shin, W.S.; Strauss, H.W.; Rockson, S. The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema. J. Nucl. Med. 2003, 44, 43–57. [Google Scholar] [PubMed]
  15. Witte, C.L.; Witte, M.H.; Unger, E.C.; Williams, W.H.; Bernas, M.J.; McNeill, G.C.; Stazzone, A.M. Advances in Imaging of Lymph Flow Disorders. Radiographics 2000, 20, 1697–1719. [Google Scholar] [CrossRef] [Green Version]
  16. Moshiri, M.; Katz, D.S.; Boris, M.; Yung, E. Using Lymphoscintigraphy to Evaluate Suspected Lymphedema of the Extremities. Am. J. Roentgenol. 2002, 178, 405–412. [Google Scholar] [CrossRef] [PubMed]
  17. Scarsbrook, A.F.; Ganeshan, A.; Bradley, K.M. Pearls and pitfalls of radionuclide imaging of the lymphatic system. Part 2: Evaluation of extremity lymphoedema. Br. J. Radiol. 2007, 80, 219–226. [Google Scholar] [CrossRef] [PubMed]
  18. Yoshida, S.; Koshima, I.; Imai, H.; Uchiki, T.; Sasaki, A.; Fujioka, Y.; Nagamatsu, S.; Yokota, K.; Harima, M.; Yamashita, S.; et al. Characteristics and outcomes of lymphaticovenular anastomosis in older patients with bilateral involvement versus younger patients with unilateral involvement in lower extremity lymphedema. J. Vasc. Surg. Venous Lymphat. Disord. 2020, 8, 646–657. [Google Scholar] [CrossRef]
  19. Yamamoto, T.; Matsuda, N.; Todokoro, T.; Yoshimatsu, H.; Narushima, M.; Mihara, M.; Uchida, G.; Koshima, I. Lower extremity lymphedema index: A simple method for severity evaluation of lower extremity lymphedema. Ann. Plast. Surg. 2011, 67, 637–640. [Google Scholar] [CrossRef] [PubMed]
  20. Executive Committee. The Diagnosis and Treatment of Peripheral Lymphedema: 2016 Consensus Document of the International Society of Lymphology. Lymphology 2016, 49, 170–184. [Google Scholar]
  21. Ciocon, J.O.; Fernandez, B.B.; Ciocon, D.G. Leg edema: Clinical clues to the differential diagnosis. Geriatrics 1993, 48, 34–40. [Google Scholar] [PubMed]
  22. Karaman, S.; Buschle, D.; Luciani, P.; Leroux, J.-C.; Detmar, M.; Proulx, S.T. Decline of lymphatic vessel density and function in murine skin during aging. Angiogenesis 2015, 18, 489–498. [Google Scholar] [CrossRef]
  23. Bruunsgaard, H.; Pedersen, M.; Pedersen, B.K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 2001, 8, 131–136. [Google Scholar] [CrossRef]
  24. Bruunsgaard, H.; Pedersen, B.K. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. N. Am. 2003, 23, 15–39. [Google Scholar] [CrossRef]
  25. Csiszar, A.; Ungvari, Z.; Koller, A.; Edwards, J.G.; Kaley, G. Aging-induced proinflammatory shift in cytokine expression profile in rat coronary arteries. FASEB J. 2003, 17, 1183–1185. [Google Scholar] [CrossRef] [PubMed]
  26. Benoit, J.N. Relationships between lymphatic pump flow and total lymph flow in the small intestine. Am. J. Physiol. 1991, 261, H1970–H1978. [Google Scholar] [CrossRef]
  27. Yoshida, S.; Koshima, I.; Imai, H.; Eldahshoury, T.E.M.; Sasaki, A.; Fujioka, Y.; Nagamatsu, S.; Yokota, K.; Harima, M.; Yamashita, S.; et al. Line production system for multiple lymphaticovenular anastomoses. J. Plast. Reconstr. Aesthetic Surg. 2019, 72, 1334–1339. [Google Scholar] [CrossRef] [PubMed]
  28. Maegawa, J.; Mikami, T.; Yamamoto, Y.; Satake, T.; Kobayashi, S. Types of lymphoscintigraphy and indications for lymphaticovenous anastomosis. Microsurgery 2010, 30, 437–442. [Google Scholar] [CrossRef] [PubMed]
  29. Yamamoto, T.; Narushima, M.; Doi, K.; Oshima, A.; Ogata, F.; Mihara, M.; Koshima, I.; Mundinger, G.S. Characteristic Indocyanine Green Lymphography Findings in Lower Extremity Lymphedema: The Generation of a Novel Lymphedema Severity Staging System Using Dermal Backflow Patterns. Plast. Reconstr. Surg. 2011, 127, 1979–1986. [Google Scholar] [CrossRef] [PubMed]
  30. Yamamoto, T.; Yoshimatsu, H.; Narushima, M.; Yamamoto, N.; Hayashi, A.; Koshima, I. Indocyanine Green Lymphography Findings in Primary Leg Lymphedema. Eur. J. Vasc. Endovasc. Surg. 2015, 49, 95–102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Schook, C.C.; Mulliken, J.B.; Fishman, S.J.; Grant, F.D.; Zurakowski, D.; Greene, A.K. Primary lymphedema: Clinical features and management in 138 pediatric patients. Plast. Reconstr. Surg. 2011, 127, 2419–2431. [Google Scholar] [CrossRef]
  32. Tiwari, A.; Cheng, K.; Button, M.; Myint, F.; Hamilton, G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch. Surg. 2003, 138, 152–161. [Google Scholar] [CrossRef]
  33. Ely, J.W.; Osheroff, J.A.; Chambliss, M.L.; Ebell, M.H. Approach to leg edema of unclear etiology. J. Am. Board Fam. Med. 2006, 19, 148–160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Roy, H.; Bhardwaj, S.; Ylä-Herttuala, S. Biology of vascular endothelial growth factors. FEBS Lett. 2006, 580, 2879–2887. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Mihara, M.; Hara, H.; Hayashi, Y.; Narushima, M.; Yamamoto, T.; Todokoro, T.; Iida, T.; Sawamoto, N.; Araki, J.; Kikuchi, K.; et al. Pathological steps of cancer-related lymphedema: Histological changes in the collecting lymphatic vessels after lymphadenectomy. PLoS ONE 2012, 7, e41126. [Google Scholar] [CrossRef] [PubMed]
  36. Chang, D.W.; Suami, H.; Skoracki, R. A prospective analysis of 100 consecutive lymphovenousbypass cases for treatment of extremity lymphedema. Plast. Reconstr. Surg. 2013, 132, 1305–1314. [Google Scholar] [CrossRef]
  37. Seki, Y.; Kajikawa, A.; Yamamoto, T.; Takeuchi, T.; Terashima, T.; Kurogi, N. Single Lymphaticovenular Anastomosis for Early-Stage Lower Extremity Lymphedema Treated by the Superior-Edge-of-the-Knee Incision Method. Plast. Reconstr. Surg. Glob. Open 2018, 6, e1679. [Google Scholar] [CrossRef] [PubMed]
  38. Mihara, M.; Hara, H.; Kikuchi, K.; Yamamoto, T.; Iida, T.; Narushima, M.; Araki, J.; Murai, N.; Mitsui, K.; Gennaro, P.; et al. Scarless lymphatic venous anastomosis for latent and early-stage lymphoedema using indocyanine green lymphography and non-invasive instruments for visualising subcutaneous vein. J. Plast. Reconstr. Aesthetic Surg. 2012, 65, 1551–1558. [Google Scholar] [CrossRef]
  39. Jørgensen, M.G.; Toyserkani, N.M.; Sørensen, J.A. The effect of prophylactic lymphovenous anastomosis and shunts for preventing cancer-related lymphedema: A systematic review and meta-analysis. Microsurgery 2018, 38, 576–585. [Google Scholar] [CrossRef]
  40. Yoshida, S.; Koshima, I.; Imai, H.; Uchiki, T.; Sasaki, A.; Fujioka, Y.; Nagamatsu, S.; Yokota, K.; Yamashita, S. Lymphovenous Anastomosis for Morbidly Obese Patients with Lymphedema. Plast. Reconstr. Surg. Glob. Open 2020, 8, e2860. [Google Scholar] [CrossRef]
  41. Lim, H.Y.; Rutkowski, J.M.; Helft, J.; Reddy, S.T.; Swartz, M.A.; Randolph, G.J.; Angeli, V. Hypercholesterolemic Mice Exhibit Lymphatic Vessel Dysfunction and Degeneration. Am. J. Pathol. 2009, 175, 1328–1337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Weitman, E.S.; Aschen, S.Z.; Farias-Eisner, G.; Albano, N.; Cuzzone, D.; Ghanta, S.; Zampell, J.C.; Thorek, D.; Mehrara, B.J. Obesity Impairs Lymphatic Fluid Transport and Dendritic Cell Migration to Lymph Nodes. PLoS ONE 2013, 8, e70703. [Google Scholar] [CrossRef] [PubMed]
  43. Troy, D.; Kish, M.; Chang, H.; Fung, H.B. Treatment of skin and soft tissue infections in the elderly: A review. Am. J. Geriatr. Pharmacother. 2010, 8, 485–513. [Google Scholar]
  44. Sugita, N.; Machikoma, T.; Echigo, T. Relationship between age-related patient background and nutritional status in cellulitis. Med. Nutr. PEN Lead. 2018, 2, 126–132. [Google Scholar]
  45. Yoshida, S.; Koshima, I.; Hamada, Y.; Sasaki, A.; Fujioka, Y.; Nagamatsu, S.; Yokota, K.; Harima, M.; Yamashita, S. Lymphovenous Anastomosis Aids Wound Healing in Lymphedema: Relationship Between Lymphedema and Delayed Wound Healing from a View of Immune Mechanisms. Adv. Wound Care 2019, 8, 263–269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Mihara, M.; Hara, H.; Furniss, D.; Narushima, M.; Iida, T.; Kikuchi, K.; Ohtsu, H.; Gennaro, P.; Gabriele, G.; Murai, N. Lymphaticovenular anastomosis to prevent cellulitis associated with lymphoedema. Br. J. Surg. 2014, 101, 1391–1396. [Google Scholar] [CrossRef] [PubMed]
  47. Yoshida, S.; Koshima, I.; Imai, H.; Sasaki, A.; Nagamatsu, S.; Yokota, K. Lymphaticovenular anastomosis for recurrent cellulitis in a dementia patient with lymphedema. J. Vasc. Surg. Cases Innov. Tech. 2020, 6, 340–343. [Google Scholar] [CrossRef] [PubMed]
  48. Deng, J.; Radina, E.; Fu, M.R.; Armer, J.M.; Cormier, J.N.; Thiadens, S.R.; Weiss, J.; Tuppo, C.M.; Dietrich, M.S.; Ridner, S.H. Self-care status, symptom burden, and reported infections in individuals with lower-extremity primary lymphedema. J. Nurs. Scholarsh. 2015, 47, 126–134. [Google Scholar] [CrossRef] [PubMed]
Figure 1. LEL index score according to type of lymphography pattern in the group ≥65 years of age. There was significant deterioration in this score with progression from the linear, LE, dDB through to the eDB pattern. dDB, distal dermal backflow; eDB, extended dermal backflow; LE, low enhancement; LEL, lower extremity lymphedema. * p < 0.05, ** p < 0.01 (Tukey–Kramer test).
Figure 1. LEL index score according to type of lymphography pattern in the group ≥65 years of age. There was significant deterioration in this score with progression from the linear, LE, dDB through to the eDB pattern. dDB, distal dermal backflow; eDB, extended dermal backflow; LE, low enhancement; LEL, lower extremity lymphedema. * p < 0.05, ** p < 0.01 (Tukey–Kramer test).
Jcm 10 05129 g001
Figure 2. Lymphatic diameters by indocyanine green pattern in the ≥65 group. There was a significant decrease in lymphatic diameter with progression from the linear, LE, dDB through to the eDB pattern. dDB, distal dermal backflow; eDB, extended dermal backflow; LE, low enhancement; LEL, lower extremity lymphedema ** p < 0.01 (Tukey–Kramer test).
Figure 2. Lymphatic diameters by indocyanine green pattern in the ≥65 group. There was a significant decrease in lymphatic diameter with progression from the linear, LE, dDB through to the eDB pattern. dDB, distal dermal backflow; eDB, extended dermal backflow; LE, low enhancement; LEL, lower extremity lymphedema ** p < 0.01 (Tukey–Kramer test).
Jcm 10 05129 g002
Figure 3. Distribution of laterality according to age of onset. The between group difference was statistically significant.
Figure 3. Distribution of laterality according to age of onset. The between group difference was statistically significant.
Jcm 10 05129 g003
Figure 4. Distribution of indocyanine green pattern according to age of onset. The between-group difference was statistically significant. dDB, distal dermal backflow; eDB, extended dermal backflow; LE, low enhancement.
Figure 4. Distribution of indocyanine green pattern according to age of onset. The between-group difference was statistically significant. dDB, distal dermal backflow; eDB, extended dermal backflow; LE, low enhancement.
Jcm 10 05129 g004
Figure 5. LEL index score before LVA according to age of onset. There was statistically significant deterioration in score with age of onset from the ≥65 group, 35–64 group, through to the <35 group. LEL, lower extremity lymphedema; LVA, lymphaticovenous anastomosis * p < 0.05, ** p < 0.01 (Tukey–Kramer test).
Figure 5. LEL index score before LVA according to age of onset. There was statistically significant deterioration in score with age of onset from the ≥65 group, 35–64 group, through to the <35 group. LEL, lower extremity lymphedema; LVA, lymphaticovenous anastomosis * p < 0.05, ** p < 0.01 (Tukey–Kramer test).
Jcm 10 05129 g005
Figure 6. Lymphatic detection rate according to age of onset. The detection rate increased significantly with increasing age of onset from the <35 group, 35–64 group, through to the ≥65 group. ** p < 0.01 (Tukey–Kramer test).
Figure 6. Lymphatic detection rate according to age of onset. The detection rate increased significantly with increasing age of onset from the <35 group, 35–64 group, through to the ≥65 group. ** p < 0.01 (Tukey–Kramer test).
Jcm 10 05129 g006
Figure 7. Lymphatic diameter according to age of onset. The lymphatic vessels became significantly more dilated with increasing age of onset from the <35 group, 35–64 group, through to the ≥65 group. ** p < 0.01 (Tukey–Kramer test).
Figure 7. Lymphatic diameter according to age of onset. The lymphatic vessels became significantly more dilated with increasing age of onset from the <35 group, 35–64 group, through to the ≥65 group. ** p < 0.01 (Tukey–Kramer test).
Jcm 10 05129 g007
Figure 8. Rate of improvement in the LEL index score according to age of onset. The improvement was significantly greater in the 35–64 and ≥65 groups than in the <35 group and was greater in the ≥65 group than in the 35–64 group. LEL, lower extremity lymphedema * p < 0.05, ** p < 0.01 (Tukey–Kramer test).
Figure 8. Rate of improvement in the LEL index score according to age of onset. The improvement was significantly greater in the 35–64 and ≥65 groups than in the <35 group and was greater in the ≥65 group than in the 35–64 group. LEL, lower extremity lymphedema * p < 0.05, ** p < 0.01 (Tukey–Kramer test).
Jcm 10 05129 g008
Figure 9. Interval between onset of lymphedema and LVA surgery according to age of onset. The interval decreased from the ≥65 group, 35–64 group, through to the <35 group. LVA, lymphaticovenous anastomosis * p < 0.05, ** p < 0.01 (Tukey–Kramer test).
Figure 9. Interval between onset of lymphedema and LVA surgery according to age of onset. The interval decreased from the ≥65 group, 35–64 group, through to the <35 group. LVA, lymphaticovenous anastomosis * p < 0.05, ** p < 0.01 (Tukey–Kramer test).
Jcm 10 05129 g009
Table 1. Patient demographics and clinical details of 86 patients with primary lymphedema affecting 150 lower limbs.
Table 1. Patient demographics and clinical details of 86 patients with primary lymphedema affecting 150 lower limbs.
Age, years67.5±19.2 (15–95)
SexFemale56 (65.1%)
Male30 (34.9%)
Body Mass Index25.42±4.76 (14.39–34.72)
Laterality of LEL, nUnilateral22 (25.6%)
Bilateral64 (74.4%)
Age at Onset of LEL (years)60.12 ± 23.27 (0–93)
Duration of Edema (years)7.39 ± 9.23 (0.2–53)
ISL StageStage Ⅰn = 64 (42.7%)
Stage Ⅱn = 66 (44%)
Stage Ⅲn = 20 (13.3%)
LEL Index Value256 ± 49 (159–380)
ICG Pattern
(Limbs)
LinearLEdDBeDB
46254039
Number of Patients by Age at Onset<35 years35-64 years≥65 years
n = 16n = 15n = 55
Age at LVA (years)35.6 ± 17.6 (15–72)59.4 ± 8.5 (44–73)79.3 ± 5.0 (70–95)
Observation Period, years1.6 ± 0.6 (0.8–2.6)
ISL, International Society of Lymphology; LEL, Lower Extremity Lymphedema; dDB, distal dermal backflow; eDB, extended dermal backflow; ICG, indocyanine green; LE, low enhancement.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Yoshida, S.; Koshima, I.; Imai, H.; Roh, S.; Mese, T.; Uchiki, T.; Sasaki, A.; Nagamatsu, S. Lymphaticovenous Anastomosis for Age-Related Lymphedema. J. Clin. Med. 2021, 10, 5129. https://doi.org/10.3390/jcm10215129

AMA Style

Yoshida S, Koshima I, Imai H, Roh S, Mese T, Uchiki T, Sasaki A, Nagamatsu S. Lymphaticovenous Anastomosis for Age-Related Lymphedema. Journal of Clinical Medicine. 2021; 10(21):5129. https://doi.org/10.3390/jcm10215129

Chicago/Turabian Style

Yoshida, Shuhei, Isao Koshima, Hirofumi Imai, Solji Roh, Toshiro Mese, Toshio Uchiki, Ayano Sasaki, and Shogo Nagamatsu. 2021. "Lymphaticovenous Anastomosis for Age-Related Lymphedema" Journal of Clinical Medicine 10, no. 21: 5129. https://doi.org/10.3390/jcm10215129

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop